when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

navitoclax dihydrochloride

$ABBVAbbVie Inc.

Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)

Tumour suppressor p53/oncoprotein Mdm2

Kartos Therapeutics Inc

Danyelza (naxitamab-gqgk)

Y-mAbs Therapeutics Inc

page 52 of 62

131

Phase 3

naxtarubicin

Refractory Acute Myeloid Leukemia

$MBRXMoleculin Biotech, Inc.

0 catalysts

Portrazza (necitumumab)

Squamous Non-Small Cell Lung Cancer

Eli Lilly and Co

nedaplatin [INN]

Esophageal Cancer

RNR BioMedical Inc

pre_registration

Non-Small Cell Lung Cancer

$NUVLNuvalent, Inc.

Chronic Lymphocytic Leukemia (CLL)

$MRKRMarker Therapeutics, Inc.

Follicular Lymphoma

$MRKMerck & Co., Inc.

Nerlynx (neratinib)

Metastatic Brain Tumor

Epidermal growth factor receptorReceptor tyrosine-protein kinase erbB-2

$PBYIPUMA BIOTECHNOLOGY, INC.

nesuparib [INN]

Pancreatic Ductal Adenocarcinoma

Onconic Therapeutics Co Ltd

Small-Cell Lung Cancer

Nilutamide Prasco (nilutamide)

Metastatic Prostate Cancer

ninsipapogene sibarnarepvec

Head And Neck Squamous Cell Carcinoma (HNSC)

$HOOKHOOKIPA Pharma Inc.

nitroxoline [INN]

Muscle Invasive Bladder Cancer (MIBC)

Asieris Pharmaceuticals (USA) Inc

nivolumab biosimilar

Xbrane Biopharma AB

nofazinlimab [INN]

Hepatocellular Carcinoma

CStone Pharmaceuticals Co Ltd

pre_registration

nogapendekin alfa

Anktiva (nogapendekin alfa)

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)

$IBRXImmunityBio, Inc.

nuvisertib hydrochloride

Secondary Myelofibrosis

Sumitomo Pharma America Inc

nuzefatide pevedotin

nuzefatide pevedotin [INN]

$BCYCBICYCLE THERAPEUTICS PLC

obecabtagene autoleucel

Aucatzyl (obecabtagene autoleucel)

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)

B-lymphocyte antigen CD19

$AUTLAutolus Therapeutics plc

oberotatug ravtansine

Adenoid Cystic Carcinoma (ACC)

Oxford BioTherapeutics Ltd

obrixtamig [INN]

Small-Cell Lung Cancer

Boehringer Ingelheim International GmbH

ocifisertib [INN]

Refractory Acute Myeloid Leukemia

Treadwell Therapeutics Inc

pre_registration

Oclaiz (octreotide)

Somatostatin receptor

odafosfamide [INN]

T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)

Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…

B-lymphocyte antigen CD20T cell surface glycoprotein CD3

$REGNREGENERON PHARMACEUTICALS, INC.

olafertinib [INN]

Non-Small Cell Lung Cancer

Checkpoint Therapeutics Inc

olaptesed pegol

olaptesed pegol [INN]

Glioblastoma Multiforme (GBM)

Non-Small Cell Lung Cancer

Eli Lilly and Co